ArticleBriefings in bioinformatics2026
PhoSARte: identification of SARS-CoV-2 phosphorylation sites using contrastive learning and protein language models.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Phosphorylation, a critical post-translational modification, is extensively altered during viral infections, including SARS-CoV-2, where it plays a central role in modulating host-pathogen interactions. Accurately identifying these specific phosphorylation sites is crucial for understanding viral pathogenesis, prioritizing antiviral targets, guiding therapeutic strategies, and strengthening preparedness for future viral outbreaks. Although several computational tools have been proposed to complement experimental phosphoproteomics, existing methods often show limited robustness, cross-viral generalizability, and interpretability. To address these challenges, we developed PhoSARte, an interpretable computational framework that integrates Siamese network-based contrastive learning (SCL) with pretrained protein language models (PLMs) to accurately identify phosphorylation sites in SARS-CoV-2-infected cells. PhoSARte employs a unique dual-stream architecture: PLMs capture contextual protein sequence representations, while the SCL module, comprising a transformer-based encoder and an attention-based bidirectional gated recurrent unit, learns discriminative and similarity-preserving representations of protein sequence pairs using a contrastive loss function. The integration of these complementary representations substantially improves the robustness and generalizability of the framework. PhoSARte was rigorously benchmarked on phosphoproteomics datasets derived from infected A549 (Homo sapiens) and Vero E6 (Chlorocebus sabaeus) cells, as well as their combined dataset. Through rigorous cross-cell-type validation and testing, PhoSARte demonstrated superior performance, significantly outperforming current state-of-the-art methods. Importantly, an external cross-viral case study on entirely unseen adenovirus type 2-infected human IMR-90 cells confirmed the broad transferability of PhoSARte, demonstrating its capacity to generate actionable biological hypotheses under novel viral stress conditions. Furthermore, advancing beyond traditional black-box predictors, PhoSARte integrates an in silico mutagenesis analysis that decodes complex deep learning embeddings to successfully extract biologically relevant motif signatures. PhoSARte is freely accessible at https://balalab-skku.org/PhoSARte/, providing an accessible, interpretable, and adaptable framework for virus-associated phosphorylation site prediction, antiviral target prioritization, and host-directed therapeutic discovery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.